Trading Update
2010年1月7日 - 4:00PM
RNSを含む英国規制内ニュース (英語)
TIDMCRYO
RNS Number : 1518F
Cryo-Save Group NV
07 January 2010
7 January 2009
Cryo-Save Group N.V.
New storage record, over 7,300 samples stored in Q4 2009 - up 18% on Q4 2008
Cryo-Save Group N.V. (AIM/Euronext: CRYO, "Cryo-Save" or "the Group"), Europe's
leading stem cell bank, stored over 7,300 samples in Q4 2009, up 18% over Q4
2008 (6,200 samples). This is the highest quarterly storage volume to date for
the Group.
The total number of samples stored for the whole of 2009 increased by 11% to
27,900 (2008: 25,200). The Group now stores in total over 120,000 samples.
In Q4 2009, 1,300 customers opted to take up the Group's additional service to
store stem cells from the umbilical cord itself, as well as from the cord blood,
bringing the total number of cord samples to 3,800.
The Group expects to publish its results for the year to 31 December 2009 during
the week commencing 22 March 2010.
Marc Waeterschoot, Chief Executive, commented:
"Despite difficult economic circumstances, the Group's double digit year on year
growth for 2009 is very positive, and has been driven by the significant growth
we have seen in Spain, Italy, Serbia and India.
"With our leading international position, the further roll out of the umbilical
cord service, combined with our profitability and healthy cash position, we are
confident of maintaining our momentum in 2010."
+-------------------------------------+----------------------------------+
| For further details: | |
+-------------------------------------+----------------------------------+
| | |
+-------------------------------------+----------------------------------+
| Cryo-Save Group | + 31 (0) 575 548 998 |
+-------------------------------------+----------------------------------+
| Marc Waeterschoot, Chief Executive | |
| Arnoud van Tulder, Chief Financial | |
| Officer | |
+-------------------------------------+----------------------------------+
| | |
+-------------------------------------+----------------------------------+
| Daniel Stewart & Company plc | + 44 (0) 20 7776 6550 |
+-------------------------------------+----------------------------------+
| Simon Leathers | |
+-------------------------------------+----------------------------------+
| | |
+-------------------------------------+----------------------------------+
| College Hill | + 44 (0) 20 7457 2020 |
+-------------------------------------+----------------------------------+
| Adrian Duffield/Rozi Morris | |
+-------------------------------------+----------------------------------+
About Cryo-Save
With more than 120,000 samples saved, Cryo-Save is the leading stem cell bank in
Europe and one of the fastest growing in the world. Driven by its international
business strategy, Cryo-Save is now represented in 38 countries on three
continents and has state-of-the-art processing facilities in Belgium, Germany,
Dubai, India and France (under construction).
Cryo-Save sets the highest quality standards in stem cell storage, as it aims to
make an important contribution to conquer possible life-threatening diseases in
the future. As a service to the public, Cryo-Save offers a Cost-free Family
Donation Programme, free of charge, to families wishing to store their newborn's
umbilical cord blood stem cells for a family member diagnosed with a
life-threatening disease treatable by stem cells. The company is committed to
further improve stem cell cryopreservation techniques, by participating in
European Commission funded projects, in Universities and Hospitals.
This information is provided by RNS
The company news service from the London Stock Exchange
END
TSTKKADPABKDBDK
Cryo-Save (LSE:CRYO)
過去 株価チャート
から 5 2024 まで 6 2024
Cryo-Save (LSE:CRYO)
過去 株価チャート
から 6 2023 まで 6 2024
Real-Time news about Cryo-Save (ロンドン証券取引所): 0 recent articles
その他のCryo-Saveニュース記事